Skip to main content

Advertisement

Log in

Establishing a renal management clinic in China: initiative, challenges, and opportunities

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Chronic kidney disease (CKD) has been identified as a growing global burden and traditional health care systems are inadequate for the management of CKD patients. This paper describes an initiative to establish a renal management clinic (RMC) in China and discusses the challenges and opportunities in the management of CKD patients.

Subjects and methods

We collected and analyzed the data for the first 1,000 CKD patients treated since the establishment of the RMC (from April 2006 to April 2007). They had CKD stages 1–4 and stage 5 (before dialysis), as described by the Kidney Outcome Quality Initiatives (KDOQI). They were managed at the RMC established at the Peking University Third Hospital, by a multidisciplinary team (nephrologists, nurses, and dietitians) who developed care plans, clinical pathways, and a multidimensional patient-education program.

Results

The most frequent causes of CKD among these 1,000 patient were glomerulonephritis (35%), hypertensive nephrosclerosis (19%), chronic interstitial nephritis (13%), and diabetic nephropathy (11%). Six percent of the patients had stage 1 CKD, 27% stage 2, 33% stage 3, 20% stage 4, and 13% had stage 5. Five hundred and fifty-four were male and 446 were female; mean age was 55 ± 18.9 years (range 18–92 years). Seven hundred and seventy patients (77%) had hypertension; 400 patients (40%) had body mass index (BMI) equal to or higher than 25 kg/m2; 180 (18%) had overt cardiovascular disease; 726 (72.6%) had low-density lipoprotein (LDL)-cholesterol higher than 2.6 mmol/l; 440 patients (44%) had hyperuriemia; and 274 patients (27.4%) had anemia (hemoglobin <110 g/l). Although the team is multidisciplinary, management of the patients in the RMC is undertaken mainly by nephrologists, whereas nurses and dietitians still do not play an important role. There are no family doctors in China and nephrologists are responsible for management of these patients’ kidney disease and related complications.

Conclusions

Our findings show that the prevalence of hypertension, diabetes mellitus, overweight. and hyperuricemia is high among Chinese CKD population. Nurses and dietitians do not yet play an important role in the present pattern of RMC. We believe that the present medical care model should be revised because it does not address the concerns of CKD patients and their need for lifestyle changes that would help them to cope with their chronic condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zhang LX, Zuo L, Xu GB, Wang F, Wang W, Wang SY et al (2007) Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant 22:1093–1099. doi:10.1093/ndt/gfl763

    Article  PubMed  Google Scholar 

  2. Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP (2001) Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol 12:1713–1720

    PubMed  CAS  Google Scholar 

  3. Kausz AT, Khan SS, Abichandani R, Kazmi WH, Obrador GT, Ruthazer R et al (2001) Management of patients with chronic renal insufficiency in the Northeastern United States. J Am Soc Nephrol 12:1501–1507

    PubMed  CAS  Google Scholar 

  4. Crooks P (2004) International care models for chronic kidney disease: methods and economics—United States. Blood Purif 22:13–20. doi:10.1159/000074919

    Article  PubMed  Google Scholar 

  5. Arora P, Mustafa RA, Karam J, Khalil P, Wilding G, Ranjan R et al (2006) Care of elderly patients with chronic kidney disease. Int Urol Nephrol 38(2):363–370. doi:10.1007/s11255-006-0046-x

    Article  PubMed  Google Scholar 

  6. Lindeman RD (2007) Hypertension and kidney protection in the elderly: what is the evidence in 2007? Int Urol Nephrol 39(2):669–678. doi:10.1007/s11255-007-9207-9

    Article  PubMed  Google Scholar 

  7. Zamboli P, De Nicola L, Minutolo R, Bertino V, Catapano F, Conte G (2006) Management of hypertension in chronic kidney disease. Curr Hypertens Rep 8:497–501. doi:10.1007/s11906-006-0029-4

    Article  PubMed  CAS  Google Scholar 

  8. Cook SA, Maclaughlin H, Macdougall IC (2008) A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease. Nephrol Dial Transplant 23:263–268. doi:10.1093/ndt/gfm511

    Article  PubMed  Google Scholar 

  9. Owen WF (2003) Patterns of care for patients with chronic kidney disease in the United States: dying for improvement. J Am Soc Nephrol 14:S76–S80. doi:10.1097/01.ASN.0000070145.00225.EC

    Article  PubMed  Google Scholar 

  10. Anand S, Nissenson AR (2002) Utilizing a disease management approach to improve ESRD patient outcomes. Semin Dial 15:38–40. doi:10.1046/j.1525-139x.2002.00012.x

    Article  PubMed  Google Scholar 

  11. Parker TF 3rd, Blantz R, Hostetter T, Himmelfarb J, Kliger A, Lazarus M et al (2004) The chronic kidney disease initiative. J Am Soc Nephrol 15:708–716. doi:10.1097/01.ASN.0000112129.20838.3F

    Article  PubMed  Google Scholar 

  12. Lameire N, Eknoyan G, Barsoum R, Eckardt KU, Levin A, Levin N et al (2004) The burden of kidney disease: improving global outcomes. Kidney Int 66:1310–1314. doi:10.1111/j.1523-1755.2004.00894.x

    Article  PubMed  Google Scholar 

  13. Peter WI, Schoolwerth AC, McGowan T, McClellan WM (2003) Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 41:903–924. doi:10.1016/S0272-6386(03)00188-4

    Article  Google Scholar 

  14. National kidney foundation (2002) Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(Suppl 1):S1–S246

    Google Scholar 

  15. Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2006) The epidemics of cardiovascular disease in elderly patients with chronic kidney disease—two facets of the same problem. Int Urol Nephrol 38(2):371–379. doi:10.1007/s11255-006-0044-z

    Article  PubMed  Google Scholar 

  16. Neves PL, Baptista A, Morgado E, Iglesias A, Carrasqueira H, Faísca M et al (2007) Anemia correction in predialysis elderly patients: influence of the antihypertensive therapy on darbepoietin dose. Int Urol Nephrol 39(2):685–689. doi:10.1007/s11255-006-9082-9

    Article  PubMed  CAS  Google Scholar 

  17. Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D (2006) Anemia, chronic renal disease and congestive heart failure-the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 38(2):295–310. doi:10.1007/s11255-006-0064-8

    Article  PubMed  Google Scholar 

  18. Spasovski GB (2007) Bone health and vascular calcifation relationships in chronic kidney disease. Int Urol Nephrol 39(4):1209–1216. doi:10.1007/s11255-007-9276-9

    Article  PubMed  CAS  Google Scholar 

  19. Grassmann A, Gioberge S, Moeller S, Brown G (2006) End-stage renal disease: global demographics in 2005 and observed trends. Artif Organs 30(12):895–897. doi:10.1111/j.1525-1594.2006.00321.x

    Article  PubMed  Google Scholar 

  20. Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, De Bacquer D et al (2006) The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant 21(1):77–83. doi:10.1093/ndt/gfi185

    Article  PubMed  Google Scholar 

  21. Wei MX, Taskapan H, Esbaei K, Jassal SV, Bargman JM, Oreopoulos DG (2006) K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them? Int Urol Nephrol 38:739–743. doi:10.1007/s11255-005-0083-x

    Article  PubMed  CAS  Google Scholar 

  22. Covic A, Gusbeth-Tatomir P, Goldsmith DJ (2007) Current dilemmas in inhibiting the renin-angiotensin system: do not forget real life. Int Urol Nephrol 39:571–576. doi:10.1007/s11255-007-9211-0

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Prof. Dimitrios G. Oreopoulos helped in the editing of this article and his assistance is greatly appreciated.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ai-Hua Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, AH., Zhong, H., Tang, W. et al. Establishing a renal management clinic in China: initiative, challenges, and opportunities. Int Urol Nephrol 40, 1053–1058 (2008). https://doi.org/10.1007/s11255-008-9450-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-008-9450-8

Keywords

Navigation